Control for Respiratory Disease
tilmicosin
Tilmovet® 90 (tilmicosin) is a Type A Medicated Article for use in Swine and Cattle Feeds.
For the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group.
Tilmovet 90 (tilmicosin) is a formulation of the antibiotic tilmicosin. Tilmicosin is produced semi-synthetically and is in the macrolide class of antibiotics. Each kilogram of Type A Medicated Article contains 200 grams (0.44 lbs) of tilmicosin adsorbed onto ground corncobs.
SWINE – For the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.
CATTLE – For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in groups of beef and nonlactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group.
Store at room temperature 25°C (77°F).
Excursions permitted to 30°C (86°F).
Avoid moisture and excessive heat 40°C (104°F).
tilmicosin
SWINE – Tilmicosin is to be fed continuously at 181 grams to 363 grams per ton (200 ppm to 400 ppm) of Type C medicated feed as the sole ration for a 21-day period, beginning approximately 7 days before an anticipated disease outbreak.
CATTLE – Tilmicosin is to be fed continuously for a single, 14 day period at 568 grams to 757 grams (626 ppm to 834 ppm) per ton on a 100% dry matter basis of Type C medicated feed as the sole ration to provide 12.5 mg/kg of body weight/day.
IMPORTANT SAFETY INFORMATION: TILMOVET® 90 (TILMICOSIN ) TYPE A MEDICATED ARTICLE: Not for Human Use. Keep out of reach of children. For use in swine and beef cattle only. Do not treat swine within 7 days of slaughter. Do not treat beef cattle within 28 days of slaughter. This drug product is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. This drug product is not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves. TILMOVET® 90 must be thoroughly mixed in swine or cattle feeds before use. Do not allow horses or other equines access to feeds containing tilmicosin. The safety of tilmicosin has not been established in cattle or male swine intended for breeding purposes.
Swine: Feed containing tilmicosin shall not be fed to pigs for more than 21 days during each phase of production without ceasing administration for re-evaluation by a licensed veterinarian. A licensed veterinarian should re-evaluate antimicrobial use before re-initiating a further course of therapy with an appropriate antimicrobial. Veterinary Feed Directive (VFD) expiration date for cattle must not exceed 90 days from the time of issuance. VFDs for tilmicosin phosphate shall not be refilled.
Cattle: Use only in cattle fed in confinement for slaughter. Tilmicosin medicated feed treatment has not been evaluated in cattle with severe clinical disease. The treatment of cattle with this medicated feed is required to be initiated within the first 45 days of the production period. The treatment should not occur concurrent with or following administration of an injectable macrolide, or within 3 days following administration of a non-macrolide injectable BRD therapy. Cattle with severe clinical illness should be evaluated for individual treatment with an alternative nonmacrolide therapy. Veterinary Feed Directive (VFD) expiration date for cattle must not exceed 45 days from the time of issuance. VFDs for tilmicosin phosphate shall not be refilled.
Avoid inhalation, oral exposure, and direct contact with skin or eyes. Operators mixing and handling TILMOVET® 90 should use protective clothing, impervious gloves, goggles, and a NIOSH-approved dust mask. Wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water. If irritation persists, seek medical attention. Keep out of reach of children. To report adverse effects, access medical information, or obtain additional product information, call 1-877-994-4883. View product label here .
